Auro Pharma Ltd acquires Khandelwal Laboratories’ non-oncology prescription business, adding 23 brands and 470 staff, boosting its pain management and anti-infective portfolio in India. Shares of Aurobindo Pharma Ltd ended higher on Thursday, January 1, by 1.18% at ₹1,197.00 on the NSE.
